Correlation Between Oncorus and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Oncorus and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Immix Biopharma, you can compare the effects of market volatilities on Oncorus and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Immix Biopharma.
Diversification Opportunities for Oncorus and Immix Biopharma
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Oncorus and Immix is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Oncorus i.e., Oncorus and Immix Biopharma go up and down completely randomly.
Pair Corralation between Oncorus and Immix Biopharma
If you would invest 163.00 in Immix Biopharma on August 24, 2024 and sell it today you would earn a total of 5.00 from holding Immix Biopharma or generate 3.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 4.55% |
Values | Daily Returns |
Oncorus vs. Immix Biopharma
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Immix Biopharma |
Oncorus and Immix Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Immix Biopharma
The main advantage of trading using opposite Oncorus and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |